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Backgrounds: Glutathione is an endogenous redox couple in animal cells and plays important roles in antioxidant
defense and detoxification, although it is unknown if oral glutathione supplementation affects exercise-induced
physiological changes. The present study investigated the effect of glutathione intake on exercise-induced muscle
metabolism and fatigue in mice and humans.
Methods: ICR mice were divided into 4 groups: sedentary control, sedentary supplemented with glutathione (2.0%,
5 μL/g body weight), exercise control, and exercise supplemented with glutathione. After 2 weeks, the exercise
groups ran on a treadmill at 25 m/min for 30 min. Immediately post-exercise, intermuscular pH was measured,
and hind limb muscle and blood samples were collected to measure biochemical parameters. In a double-blind,
cross-over study, 8 healthy men (35.9 ± 2.0 y) were administered either glutathione (1 g/d) or placebo for 2 weeks.
Then, they exercised on a cycle ergometer at 40% maximal heart rate for 60 min. Psychological state and blood
biochemical parameters were examined after exercise.
Results: In the mouse experiment, post-exercise plasma non-esterified fatty acids were significantly lower in the
exercise supplemented with glutathione group (820 ± 44 mEq/L) compared with the exercise control group
(1152 ± 61 mEq/L). Intermuscular pH decreased with exercise (7.17 ± 0.01); however, this reduction was prevented
by glutathione supplementation (7.23 ± 0.02). The peroxisome proliferator-activated receptor-γ coactivator-1α protein
and mitochondrial DNA levels were significantly higher in the sedentary supplemented with glutathione group
compared with the sedentary control group (25% and 53% higher, respectively). In the human study, the elevation of
blood lactate was suppressed by glutathione intake (placebo, 3.4 ± 1.1 mM; glutathione, 2.9 ± 0.6 mM). Fatigue-related
psychological factors were significantly decreased in the glutathione trial compared with the placebo trial.
Conclusions: These results suggest that glutathione supplementation improved lipid metabolism and acidification in
skeletal muscles during exercise, leading to less muscle fatigue.
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Glutathione, a tripeptide consisting of glutamate, cyst-
eine, and glycine, is synthesized primarily in the hepatic
cells. It is stored in an oxidized or reduced form at high
concentrations in the majority of cells. Glutathione is
reported to be involved in the regulation of various
physiological functions, in particular, antioxidation and
detoxification functions [1,2]. Reduced glutathione is
easily oxidized by reactive oxygen species and subse-
quently reduced again by glutathione reductase, and the
redox balance of glutathione has been used as a marker
of antioxidant status in various conditions. Physical exer-
cise decreases the reduced form and increases the oxi-
dized form of glutathione [3,4]. In addition, prolonged
exercise decreases total plasma and tissue glutathione
content over time [5,6], which suggests that glutathione
may be associated with aerobic energy metabolism and
maintenance of muscle contraction.
Energy and nutrient metabolism in skeletal muscle
plays an important role in muscular fatigue. In particu-
lar, the energy source can affect muscle performance.
For example, a carbohydrate-based energy source results
in decreased muscular pH owing to increased lactic acid
production, which leads to impaired muscle contraction.
However, when the energy expended during exercise is
derived from lipids, a large amount of energy can be
continuously supplied via aerobic metabolism. There-
fore, increased lipid utilization in the mitochondria of
skeletal muscle cells is associated with continued muscle
contraction, and the number and activity of mitochon-
dria influence the utilization of fatty acids in muscle
cells.
Over the past decade, peroxisome proliferator-activated
receptor-γ coactivator-1α (PGC-1α) has been demon-
strated as a key transcriptional co-activator, providing a
mechanistic insight into nuclear regulatory pathways in
the biogenesis of mitochondria in skeletal muscle [7-9].
Its contents are changed by differing levels of physical
activity, metabolic disorders, and aging, which are all
associated with metabolic capacity [9-11]. Moreover, it
interacts with nuclear receptors and transcription fac-
tors to activate the transcription of lipid metabolic
genes, and its activity is responsive to aerobic metabolic
events [9,10].
Recently, Kovacs-Nolan et al. [12] demonstrated, in
in vitro and ex vivo intestinal absorption model, that in-
tact glutathione can be transported across human intes-
tinal epithelial cells. In addition, we reported that the
plasma glutathione concentration is transiently elevated
after oral glutathione supplementation [13], which sug-
gests that exogenous glutathione can be absorbed into
the body and act as an important glutathione supply.
Therefore, we hypothesized that glutathione supplemen-
tation may contribute to aerobic metabolism duringexercise as a result of activated mitochondria via PGC-
1α in skeletal muscle. The purpose of this study was to
examine the effects of glutathione supplementation on




This study complied with the guidelines of the Japanese
Council on Animal Care and was approved by the Com-
mittee for Animal Research at Kyoto Prefectural Univer-
sity of Medicine (No. 23–77). ICR mice (7-week-old;
Shimizu Laboratory Supplies, Kyoto, Japan) were accli-
matized for 1 week in an air-conditioned (22 ± 2°C)
room on a 12-h light/dark cycle (lights on from 7:30 to
19:30). Mice were divided into 4 groups containing 8 an-
imals each: sedentary control, sedentary supplemented
with glutathione, exercise control, and exercise supple-
mented with glutathione. Glutathione was purified and
crystalized after separation from the fermented food-
grade yeast Candida utilis which approved by the U.S.
food and drug administration (FDA), and used for
experiments.
A glutathione solution (2% w/w) was provided 1 time
per d (5 μL/g body weight) for 2 weeks. Saline was pro-
vided to control mice in the same volume. After 2 weeks
of treatment, the exercise groups ran on a treadmill;
after an initial 5-min warm up, the running speed was
gradually increased to 25 m/min, which was maintained
for 30 min. Immediately following the exercise, inter-
muscular pH was measured under anesthesia; then the
hind limb muscles and blood were collected. The control
mice underwent the same measurements. Blood glucose
was measured (GluTest; Arkray, Inc., Kyoto, Japan), fol-
lowing which the blood samples were centrifuged at
3,500 rpm for 15 min at 4°C to collect plasma. Plasma
nonesterified fatty acid (NEFA) was measured using a
NEFA-C assay kit (WAKO, Osaka, Japan).
pH measurements in animals
pH levels in the interstitial fluid of exercised muscle tis-
sue were measured under anesthesia using a glass micro-
electrode that was inserted into the interstitium between
the gastrocnemius and tibialis anterior muscles.
Western blotting
Protein was extracted from muscle tissues obtained from
sedentary groups using a lysis buffer (Sigma, St. Louise,
MO) containing protease inhibitor. Equal amounts of
protein in the lysates were separated by 10% sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis, and pro-
teins were then transferred onto nitrocellulose membrane.
The blots were incubated with primary antibodies against
PGC-1α (Chemicon International, Temecula, CA) and
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Technology, Beverly, MA), and the reaction products were
visualized using a horseradish peroxidase-conjugated sec-
ondary antibody (Invitrogen, Carlsbad, CA) and enhanced
chemiluminescence (Chemi-Lumi One Super, Nakarai
Tesque, Kyoto, Japan) (Additional file 1: Figure S1). Band
densities were measured using ImageQuant LAS4000
(GE Healthcare, Buckinghamshire, UK).
Mitochondrial DNA
To determine the mitochondrial DNA (mtDNA), poly-
merase chain reaction (PCR) analysis was performed using
DNA obtained from muscle tissues. Total DNA was ex-
tracted using the extraction reagent (DNA zol® BD Re-
agent, Invitrogen) following homogenization. The relative
copy numbers of mitochondrial to nuclear DNA were de-
termined by real-time PCR with primers specific to cyto-
chrome c oxidase subunit II (COX II) (mitochondrial)
5′-ATCCCAGGCCGACTAAATCA (forward) and 5′-TT
TCAGAGCATTGGCCATAGAA (reverse) and β-actin
(nuclear) genes 5′-TATCCACCTTCCAGCAGATGT (for-
ward) and 5′-AGCTCAGTAACAGTCCGCCTA (reverse).
Human experimental design
Eight healthy men (age, 35.9 ± 2.0 y; height, 172.6 ±
1.9 cm; body weight, 70.6 ± 3.2 kg; BMI, 23.8 ± 1.2 kg/m2)
were recruited to participate in a double-blind, cross-over
study, which was complied with the principles outlined in
the Helsinki Declaration and approved by the ethics com-
mittee of Kyoto Prefectural University (No. 46). All of the
subjects provided written, informed consent. The subjects
did not have a current or prior chronic disease or a history
of smoking, and they were not currently using any
medications. The subjects were also not habituated to a
regular exercise regimen.
A single-bout exercise experiment was performed fol-
lowing 2 weeks of glutathione (1 g/d) or placebo supple-
mentation in capsule form. The subjects were asked to
fast, except for water, from 22:00 the night prior to the
experiment. On the experiment day, all subjects con-
sumed the same breakfast (200 g of steamed rice)
90 min before the exercise session to normalize the ef-
fects of a pre-exercise meal. All participants performed a
single bout of steady-state cycling exercise at 40% max-
imum heart rate for 60 min. Heart rate and the rating of
perceived exertion (RPE; Borg scale) were monitored
every 10 min during exercise. Blood samples were col-
lected from the antecubital vein before and after exer-
cise, and blood glucose and lactate were measured using
simple measuring instruments (Lactate Pro, GluTest;
Arkray, Kyoto, Japan). Data obtained from seven subjects
was analyzed for glucose and lactate due to failure of
blood collection during exercise for one subject. Psycho-
logical state was assessed after blood collection using theProfile of Mood State test, of which we were interested
in 2 mood factors (fatigue–inertia and vigor–activity). In
addition, the degree of relaxation was examined using a
visual analogue scale (VAS). A 4-week washout period
separated the conditions, and all of the subjects com-
pleted both testing conditions.
Measurement of plasma glutathione
Plasma glutathione concentration was measured according
to our previously reported protocol [13]. Briefly, collected
plasma was mixed with ethanol and then centrifuged. The
supernatant was dried and added to 5% trichloroacetic
acid (TCA) containing 2% 2-mercaptoethanol to reduce
the oxidized form of glutathione, and the mixture was
used as the deprotenized plasma fraction. The ethanol
precipitate of the plasma was mixed with the 5% (final
concentration) TCA and 2% 2-mercaptoethanol. After
centrifugation, the supernatant was used as the protein-
bound plasma fraction. The concentrations of both
fractions were determined by precolumn derivation
with 6-aminoquinolyl-N-hydroxy succinimidyl carbamate
and liquid chromatography-tandem mass spectrometry
(LC-MS/MS).
Statistical analysis
All data are reported as mean ± SE. Differences between
groups or time course comparisons were evaluated using
2-way ANOVA. When significant interactions were de-
tected, post hoc multiple comparisons were conducted
using the Bonferroni method. Differences between the
control and glutathione groups in the animal study were
determined using Student’s t-tests. Differences between
the placebo and glutathione trials in the human study
were tested using Wilcoxon signed-rank tests. P < 0.05
was considered statistically significant.
Results
Body weight and blood parameters in animals
Body weight was similar in all of the groups (sedentary
control, 41.4 ± 0.9 g; sedentary supplemented with gluta-
thione, 39.8 ± 0.9 g; exercise control 41.3 ± 0.8 g; exercise
supplemented with glutathione, 40.2 ± 0.7 g). There were
no significant differences in blood glucose levels between
the control and glutathione groups in both sedentary and
exercise conditions (degree of freedom (df ) = 31, F =
0.039) (Figure 1A). In contrast, plasma NEFA after exer-
cise was significantly lower with supplementation of gluta-
thione compared with the control group (df = 31, F = 5.90,
p < 0.01) (Figure 1B).
Intermuscular pH in animals
The interstitial pH levels in muscle were significantly re-
duced by exercise (df = 31, F = 4.36, p < 0.001; Figure 1C).
However, the pH following exercise of the glutathione
Figure 1 The effect of glutathione on blood glucose (A), NEFA (B), and intermuscular pH (C) in sedentary and exercised mice. Values are
provided as mean ± SE. *p < 0.05, **p < 0.01, ***p < 0.001.
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group (p < 0.05).
PGC-1α, AMPK, and mitochondrial DNA in mouse muscle
PGC-1α was significantly higher with glutathione intake
(df = 14, t = −1.88, p < 0.05; Figure 2A). In addition,
AMPK, an upstream protein of PGC-1α, was also signifi-
cantly higher in the sedentary treated with glutathione
group than in the sedentary control group (df = 13, t =
−2.76, p < 0.05; Figure 2B). In addition, mtDNA was sig-
nificantly higher with glutathione supplementation (df =
14, t = −1.98, p < 0.05; Figure 2C).
Blood biochemical parameters in humans
There was a significant decrease in the blood glucose
concentrations at 30 and 60 min after exercise compared
with pre-exercise in both the placebo and glutathione
trials (df = 41, F = 23.9, p < 0.01) (Figure 3A); however,
there was no difference between the trials. There was a
significant increase in blood lactate concentrations at30 min after exercise compared with pre-exercise in the
placebo trial (df = 41, F = 3.90, p < 0.05) but not in the
glutathione trial (Figure 3B). The free form of glutathi-
one in plasma was not changed by either exercise or
glutathione intake. In contrast, protein-bound plasma
glutathione was significantly reduced by exercise in the
placebo trial (p < 0.05) although the reduction was moder-
ated in the glutathione-supplemented group (Figure 4).
Heart rate and psychological parameters in humans
There was a trend for lower heart rates during exercise
at 40 and 60 min in the glutathione trial compared with
the placebo trial (Z = −1.47, p = 0.071 and Z = −1.26, p =
0.104, respectively) (Figure 5). There was also a trend for
a lower RPE at 50 min (Z = −1.44, p = 0.075) and a sig-
nificant decrease at 60 min (Z = −1.78, p < 0.05) in the
glutathione trial compared with the placebo trial.
The Profile of Mood State vigor–activity factor after
exercise was significantly higher following exercise in
the glutathione trial compared with the placebo trial
Figure 2 The effect of glutathione on PGC-1α (A), AMPK (B) and mtDNA (C) levels in skeletal muscle in sedentary mice. Values are provided
as mean ± SE. *p < 0.05.
Figure 3 The effect of glutathione on blood glucose (A) and lactate (B) level in humans. Values are provided as the mean ± SE. *p < 0.05,
**p < 0.01 vs. Rest.
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Figure 4 The effect of glutathione on plasma ethanol-soluble (A) and protein-bound (B) glutathione level in humans. Values are provided as
the mean ± SE. *p < 0.05.
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inertia factor was significantly lower in the glutathione
trial compared with the placebo trial (Z = −1.82, p <
0.05), while marked difference was not found in the
VAS scores between trials (Z = −0.98, p = 0.163).
Discussion
In the present study, glutathione supplementation
resulted in higher levels of PGC-1α and mtDNA bio-
genesis in mouse skeletal muscle and prevented the
exercise-induced reduction in intermuscular pH in mice.
Moreover, in humans, glutathione supplementation sup-
pressed fatigue-related parameters during and after exer-
cise. While it has been well documented that glutathione
plays a central role in the antioxidant network in animal
cells and redox balance can act as a marker of antioxidant
status in various pathological and physiological conditionsFigure 5 The effect of glutathione on heart rate (A) and the rating of p
mean ± SE. *p < 0.05 vs. placebo.including exercise [3,4,14,15], the role of exogenous gluta-
thione on phenotypic changes relating to physical exercise
has not been explored. To the best of our knowledge, the
present study is the first to demonstrate that glutathi-
one supplementation improves aerobic metabolism in
skeletal muscle, leading to reduced exercise-induced
muscle fatigue.
During muscle contraction, lactic acid, a major source
of protons, is rapidly produced by increased glycolytic
metabolism, lowering the pH and inhibiting muscle con-
traction [16]. The protons generated from cytosolic lac-
tic acid are immediately buffered in the cell or exported
to the interstitial fluid and further transported to the
blood. The buffering capacity is relatively high in the
cytosol and blood, whereas this capacity is low in inter-
stitial fluid where the presence of buffering factors, such
as proteins, is limited [17,18]. Therefore, the pH of theerceived exertion (B) level in in humans. Values are provided as the
Table 1 Psychological examination after exercise
Placebo Glutathione
POMS test
Vigor-activity 54.5 ± 2.8 58.8 ± 3.2*
Fatigue-inertia 51.0 ± 2.8 45.1 ± 2.7*
VAS 6.0 ± 0.7 4.7 ± 0.8
Values are provided as mean ± SE. *p < 0.05 vs. placebo.
POMS, Profile of Mood State; VAS, visual analogue scale.
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in response to muscle contraction and can also be a
marker of acid–base conditions in muscle tissue. In con-
trast, the majority of lactate anions are released into the
circulation or immediately metabolized as an energy
substrate through aerobic metabolism [19-21]; therefore,
their levels are not suitable as a marker. The results of
both the animal and human studies indicate that gluta-
thione supplementation inhibited the decrease in inter-
muscular pH after exercise; in the human study, this was
demonstrated by the differences in blood lactate concen-
trations following exercise between the placebo and
glutathione trials. These results may also explain the dif-
ferences observed between the trials in RPE and subject-
ive fatigue during and after exercise; in particular, an
improvement in muscular acidosis results in less fatigue.
Circulating NEFA concentrations are regulated by a
balance between catabolic processes in adipose tissue
and fatty acid substrate utilization by the skeletal muscle.
Circulating catecholamines such as adrenalin and nor-
adrenalin are increased in response to exercise and
stimulate lipolysis of triglycerides in adipose tissue [22],
which causes an elevation of circulating fatty acids. In
contrast, muscle contraction increases uptake of fatty
acids from the circulation into muscle cells [23], which
leads to a decrease in circulating fatty acids. Therefore,
we suggest that the reduction of NEFA observed in the
glutathione-supplemented mice was due to an increase
in muscle utilization rather than a release from adipose
tissue. Because energy consumed in muscle during exer-
cise is mainly supplied by carbohydrates and lipids,
glutathione-induced lipid utilization can decrease energy
obtained from carbohydrates, which may lead to a de-
crease in lactate/proton production. Collectively, this in-
dicates that glutathione improves metabolic acidosis
through the activation of lipid metabolism, which leads
to suppression of exercise-induced fatigue.
PGC-1α is a central member of a family of transcrip-
tional co-activators involved in aerobic metabolism. Acti-
vation of PGC-1α alters the metabolic phenotype through
interactions with nuclear respiratory factor and peroxi-
some proliferator-activated receptor-α [8-10], which leads
to increased mitochondrial biogenesis and activity. It hasbeen reported that PGC-1α activation causes significant
improvements in athletic performance [24,25], preven-
tion and treatment of muscle weakness in the elderly,
obesity, and other metabolic diseases such as mitochon-
drial myopathies and diabetes [10,11,26]. Here, we de-
tected an increase in PGC-1α with 2 weeks of glutathione
intake, along with an increase in mtDNA content, indicat-
ing the activation of mitochondrial biogenesis. Therefore,
the observed elevation of PGC-1α by glutathione intake
strongly suggests an acceleration in lipid metabolism. In
addition, the increase of mitochondria content could also
lead to a decrease of lactate generation by accelerating
aerobic metabolism of glucose, which would prevent
muscle acidosis during exercise even further.
The regulatory mechanism for glutathione-induced in-
creases in PGC-1α is unclear. One explanation is the ele-
vation of AMPK, which is an upstream factor of PGC-1α
regulation [27,28]. Recently, it has been argued that oral
intake of other antioxidants, including vitamin C and E,
do not elevate PGC-1α in the skeletal muscle of mice and
humans [29,30]; thus, this may be a specific action of
glutathione as a signal factor, but not its antioxidant prop-
erties. We found that 2 weeks of glutathione supplementa-
tion did not affect plasma glutathione concentration in
the basal state. However, glutathione is transported across
the intestines with in its intact form [12], and its plasma
concentration, along with the glutathione-derived dipep-
tides γ-glutamyl-cysteine and cysteinyl-glycine, is mark-
edly elevated during the 60–120-min period after oral
administration, as shown in our previous report [13].
Therefore, the transient elevation of glutathione or the de-
rived dipeptides following supplementation over 2 weeks
may indicate stimulation of specific signaling factors that
lead to elevated AMPK and PGC-1α. Alternatively, gluta-
thione content in muscle tissues may also increase with
supplementation, leading to the up-regulation of these fac-
tors. Further studies are needed to determine the specific
mechanism(s) by which glutathione affects muscle aerobic
metabolism. In addition, we also observed that reduction
of the protein-bound glutathione concentration in plasma
after exercise was suppressed following glutathione
supplementation, which may also be related to the
regulation of energy metabolism or fatigue. Future studies
should also aim to identify the bound protein in plasma
and examine the mechanism of protein binding or release
from the protein and its source.
Conclusions
The present results demonstrated that 2 weeks of gluta-
thione supplementation decreased plasma fatty acids
and suppressed the exercise-induced reduction in inter-
muscular pH. Glutathione supplementation also resulted
in elevated concentrations of PGC-1α and mitochon-
dria in skeletal muscle. These observations suggest that
Aoi et al. Journal of the International Society of Sports Nutrition  (2015) 12:7 Page 8 of 8glutathione induces aerobic metabolism and improves
an acidic environment in skeletal muscle during exercise
by elevating PGC-1α, which would prevent exercise-
induced fatigue.
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Additional file 1: Figure S1. Images of western blotting for PGC-1α,
AMPK, and β-actin in control (C) and glutathione (G) groups.
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